Webinars
AMGA webinars offer a one-hour, live learning opportunity on a variety of subjects and allow you to engage with the presenters through Q&A.
Unable to participate in a live webinar? Visit AMGA's Webinar Archives to access up to one year of content listings or browse all available webinar content by visiting the AMGA Solutions Library and searching by “Resource Type.”
All webinars marked “ Eligible for Continuing Education Credit ” have been made eligible as live educational activities for which live participants may claim 1 hour of CME and ACHE Qualified Education credit. Click here for details.
The Art of the Possible with AI in Population Health Management
Wednesday, January 28, 12:00 pm ET
Sponsored by Lightbeam
Evan Huang, Chief Technical Officer
Mike Hoxter, Chief Technology Officer
Andy De, Chief Marketing Officer, Lightbeam Health
AI spending in healthcare and life sciences is projected to grow from $11.6 billion in 2024 to $19 billion by 2027, with a five-year compound annual growth rate of 16.6%, per Gartner. However, a majority of these investments have focused on generative AI / large language models that have delivered limited value and ROI in healthcare, comprising a few use cases like Ambient Clinical Intelligence, a.k.a. “ambient listening,” capturing physicians notes and customer self-service applications. This presentation will deliver a forward-looking point of view on “A Portfolio Management Approach to AI in Healthcare” and present real-world AI-enabled use cases in population health management deployed by leading accountable care organizations and integrated delivery networks, which have resulted in over 40% reduction in 30-60-90 day readmissions while saving millions of dollars in avoidable costs of care, assuring superior patient outcomes for their Medicaid members.
Key Takeaways:
- The portfolio management approach to applying AI in healthcare
- Real-world AI use cases that have been deployed in population health management
- The impact of AI on reducing readmissions, improving patient outcomes, and lowering healthcare costs
Improving Cardiovascular Outcomes in Patients at High Risk
Wednesday, February 11, 12:00 pm ET
Sponsored by Amgen, Inc.
Raj Sugumaran, MD, Heart One Associates & Banner Health
Millions of new patients are diagnosed each year with clinical ASCVD, many without a prior heart attack or stroke. Despite treatment, patients continue to have higher LDL-C levels than thresholds recommended by guidelines. Additionally, CV events result in substantial financial costs for health systems. New outcomes data reveal that aggressive LDL-C lowering can reduce the risk of first cardiovascular events among patients with atherosclerosis or diabetes and without prior MI or stroke. Join us as we unpack the landmark VESALIUS-CV trial, explore real-world treatment gaps, and discuss how Repatha® reshapes prevention strategies across an expanded ASCVD risk spectrum.
Key Takeaways:
- First-ever CV outcomes data demonstrating benefit in high-risk patients without prior MI or stroke (VESALIUS-CV)
- Clear demonstration that lower for longer drives improved outcomes across populations
- Evidence-based opportunities for your health system: pharmacy-led lipid programs, EHR-driven identification, and standardized care pathways
Help Prevent RSV Lower Respiratory Tract Disease in Infants in Their First RSV Season
Thursday, March 19, 12:00 pm ET
Sponsored by Merck
Nicole Parkerson, MD, Regional Director, Merck & Co., Inc.
By Joining this 60-minute webinar, attendees will gain insights on:
Key Takeaways:
- RSV lower respiratory tract disease in infants
- An option to help prevent RSV lower respiratory tract disease in infants during their first RSV season
- Infant passive RSV immunization recommendations and practical considerations
Interested in sponsoring webinar content to share with AMGA Members?
Please contact Colleen Stern at cstern@amga.org
Advertisement